Evaluation of the ability of carprofen and flunixin meglumine to inhibit activation of nuclear factor kappa B. [electronic resource]
Producer: 20030603Description: 211-5 p. digitalISSN:- 0002-9645
- Animals
- Anti-Inflammatory Agents, Non-Steroidal -- pharmacology
- Carbazoles -- pharmacology
- Cell Line
- Clonixin -- analogs & derivatives
- Cyclooxygenase Inhibitors -- pharmacology
- Enzyme Induction -- drug effects
- Inflammation -- drug therapy
- Inhibitory Concentration 50
- Lipopolysaccharides -- pharmacology
- Macrophages -- drug effects
- Mice
- NF-kappa B -- antagonists & inhibitors
- Nitric Oxide Synthase -- metabolism
- Nitric Oxide Synthase Type II
- Phenylbutazone -- pharmacology
- Prostaglandin-Endoperoxide Synthases -- metabolism
- Prostaglandins -- biosynthesis
- Sheep
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.